TTE:EURONEXT PARISTotalEnergies SE Analysis
Data as of 2026-06-09 - not real-time
$88.48
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
TotalEnergies is trading at €88.48, modestly below its 20‑day (90.23) and 50‑day (90.42) SMAs, with a neutral RSI (44.8) and a bearish MACD histogram, suggesting short‑term pressure around the $86.66 support level. Volatility remains elevated at 23.6% over the past 30 days, but the beta of –0.10 indicates very low systematic risk, and volume is trending higher, hinting at renewed buying interest.
Fundamentally, the stock offers a compelling value proposition: a trailing PE of 13.1 versus an industry average of 21.4, a forward PE of 8.8, and a dividend yield of 4.76% supported by a 58.8% payout ratio and robust free cash flow. Analyst consensus points to upside of roughly 10% (target median €103), and recent shareholder‑friendly news—such as the employee‑focused capital increase—adds a modest catalyst for demand.
Fundamentally, the stock offers a compelling value proposition: a trailing PE of 13.1 versus an industry average of 21.4, a forward PE of 8.8, and a dividend yield of 4.76% supported by a 58.8% payout ratio and robust free cash flow. Analyst consensus points to upside of roughly 10% (target median €103), and recent shareholder‑friendly news—such as the employee‑focused capital increase—adds a modest catalyst for demand.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price testing support at €86.66 with bearish MACD
- Neutral RSI and high short‑term volatility
- Increasing volume but no clear breakout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to peers (PE 13.1 vs 21.4 industry)
- Attractive dividend yield and sustainable payout
- Analyst price targets imply ~10% upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified global asset base reducing geographic risk
- Strategic shift toward renewables and low‑carbon fuels
- Strong balance sheet with manageable net debt and solid cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth3.40%
Profit Margin8.20%
P/E Ratio13.1
ROE12.51%
ROA4.89%
Debt/Equity51.30
P/B Ratio1.7
Op. Cash Flow$28.1B
Free Cash Flow$10.1B
Industry P/E21.4
Technical Analysis
TrendNeutral
RSI44.8
Support$86.66
Resistance$94.17
MA 20$90.23
MA 50$90.42
MA 200$73.57
MACDBearish
VolumeIncreasing
Fear & Greed Index85.95
Valuation
Fair Value$52.80
Target Price$97.19
Upside/Downside9.84%
GradeFair
TypeBlend
Dividend Yield4.76%
Risk Assessment
Beta-0.10
Volatility23.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.